对《甲氧苄啶-磺胺甲恶唑与左氧氟沙星治疗感染：一项对154家美国医院电子健康记录的回顾性比较有效性研究》的勘误
Correction to: Trimethoprim-Sulfamethoxazole Versus Levofloxacin for Infections: A Retrospective Comparative Effectiveness Study of Electronic Health Records from 154 US Hospitals.
出版信息
Open Forum Infect Dis. 2023 Apr 26;10(4):ofad198. doi: 10.1093/ofid/ofad198. eCollection 2023 Apr.
Abstract
[This corrects the article DOI: 10.1093/ofid/ofab644.].
摘要
[本文更正了文章的数字对象标识符：10.1093/ofid/ofab644。]
相似文献
1
Correction to: Trimethoprim-Sulfamethoxazole Versus Levofloxacin for Infections: A Retrospective Comparative Effectiveness Study of Electronic Health Records from 154 US Hospitals.对《甲氧苄啶-磺胺甲恶唑与左氧氟沙星治疗感染：一项对154家美国医院电子健康记录的回顾性比较有效性研究》的勘误
Open Forum Infect Dis. 2023 Apr 26;10(4):ofad198. doi: 10.1093/ofid/ofad198. eCollection 2023 Apr.
2
Trimethoprim-Sulfamethoxazole Versus Levofloxacin for Infections: A Retrospective Comparative Effectiveness Study of Electronic Health Records from 154 US Hospitals.甲氧苄啶-磺胺甲恶唑与左氧氟沙星治疗感染的比较：一项对美国154家医院电子健康记录的回顾性疗效研究
Open Forum Infect Dis. 2022 Jan 17;9(2):ofab644. doi: 10.1093/ofid/ofab644. eCollection 2022 Feb.
3
Sulfamethoxazole/trimethoprim versus fluoroquinolones for the treatment of Stenotrophomonas maltophilia bloodstream infections.复方磺胺甲噁唑/甲氧苄啶与氟喹诺酮类药物治疗嗜麦芽窄食单胞菌血流感染的比较。
J Glob Antimicrob Resist. 2018 Mar;12:104-106. doi: 10.1016/j.jgar.2017.09.015. Epub 2017 Sep 28.
4
Fluoroquinolones versus trimethoprim-sulfamethoxazole for the treatment of Stenotrophomonas maltophilia infections: a systematic review and meta-analysis.氟喹诺酮类药物与复方磺胺甲噁唑治疗嗜麦芽窄食单胞菌感染的疗效比较：系统评价和荟萃分析。
Clin Microbiol Infect. 2019 May;25(5):546-554. doi: 10.1016/j.cmi.2018.11.008. Epub 2018 Nov 16.
5
Activity of Potential Alternative Treatment Agents for Stenotrophomonas maltophilia Isolates Nonsusceptible to Levofloxacin and/or Trimethoprim-Sulfamethoxazole.潜在替代治疗剂对左氧氟沙星和/或复方磺胺甲噁唑不敏感的嗜麦芽窄食单胞菌分离株的活性。
J Clin Microbiol. 2020 Jan 28;58(2). doi: 10.1128/JCM.01603-19.
6
Can levofloxacin be a useful alternative to trimethoprim-sulfamethoxazole for treating Stenotrophomonas maltophilia bacteremia?左氧氟沙星可否替代复方磺胺甲噁唑治疗嗜麦芽窄食单胞菌菌血症？
Antimicrob Agents Chemother. 2014;58(1):581-3. doi: 10.1128/AAC.01682-13. Epub 2013 Oct 14.
7
Emergence of concurrent levofloxacin- and trimethoprim/sulfamethoxazole-resistant Stenotrophomonas maltophilia: Risk factors and antimicrobial sensitivity pattern analysis from a single medical center in Taiwan.嗜麦芽寡养单胞菌同时耐左氧氟沙星和复方磺胺甲噁唑的出现：来自台湾单一医疗中心的危险因素和抗菌药物敏感性分析。
J Microbiol Immunol Infect. 2022 Feb;55(1):107-113. doi: 10.1016/j.jmii.2020.12.012. Epub 2021 Jan 13.
8
Clinical and Microbiologic Outcomes in Patients with Monomicrobial Stenotrophomonas maltophilia Infections.单一致病菌嗜麦芽寡养单胞菌感染患者的临床和微生物学结局。
Antimicrob Agents Chemother. 2019 Oct 22;63(11). doi: 10.1128/AAC.00788-19. Print 2019 Nov.
9
Risk factors and molecular mechanisms associated with trimethoprim-sulfamethoxazole resistance in Stenotrophomonas maltophilia in Mexico.墨西哥嗜麦芽窄食单胞菌中与甲氧苄啶-磺胺甲恶唑耐药相关的危险因素及分子机制
J Med Microbiol. 2017 Aug;66(8):1102-1109. doi: 10.1099/jmm.0.000550. Epub 2017 Aug 4.
10
Activity of Cefiderocol Alone and in Combination with Levofloxacin, Minocycline, Polymyxin B, or Trimethoprim-Sulfamethoxazole against Multidrug-Resistant Stenotrophomonas maltophilia.头孢地尔单独及与左氧氟沙星、米诺环素、多粘菌素B或复方磺胺甲恶唑联合使用对多重耐药嗜麦芽窄食单胞菌的活性。
Antimicrob Agents Chemother. 2020 Aug 20;64(9). doi: 10.1128/AAC.00559-20.
引用本文的文献
1
Isolation and characterization of novel bacteriophages targeting Stenotrophomonas maltophilia.靶向嗜麦芽窄食单胞菌的新型噬菌体的分离与鉴定
Sci Rep. 2025 Aug 13;15(1):29743. doi: 10.1038/s41598-025-14811-5.
Zotero 插件